| Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch - Nyxoid 1,8 mg, Nasenspray | | 66930 | | 01 | | Nyxoid 1,8 mg | | Nasenspray | | V03AB15 | | Naloxon | | 12.07.2018 | | |
| | Composition | | naloxoni hydrochloridum dihydricum 2.2 mg corresp. naloxoni hydrochloridum anhydricum 2 mg corresp. naloxonum 1.8 mg, trinatrii citras dihydricus, natrii chloridum, acidum hydrochloridum concentratum q.s. ad pH, natrii hydroxidum q.s. ad pH, nitrogenia q.s., aqua purificata q.s. ad solutionem, solutio 100 µl et propellentia ad aerosolum corresp. natrium 0.14 mg. | | Packungsbestandteile | | Spray nasale | | | | | | | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum Concentratum | | | Naloxone Hydrochloride Dihydrate | 2.2 mg | | Sodium Chlorure | | | Trinatrii Citras Dihydricus | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 2 | | | B | | Oui |
|
|
